These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34870338)

  • 21. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
    Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pheochromocytoma: When to search a germline defect?
    Buffet A; Burnichon N; Amar L; Gimenez-Roqueplo AP
    Presse Med; 2018; 47(7-8 Pt 2):e109-e118. PubMed ID: 30100270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.
    Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK
    Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study.
    Favier J; Meatchi T; Robidel E; Badoual C; Sibony M; Nguyen AT; Gimenez-Roqueplo AP; Burnichon N
    Mod Pathol; 2020 Jan; 33(1):57-64. PubMed ID: 31383958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
    Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
    J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma.
    Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
    Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical genetics of phaeochromocytoma and paraganglioma.
    Kavinga Gunawardane PT; Grossman A
    Arch Endocrinol Metab; 2017 Oct; 61(5):490-500. PubMed ID: 29166454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience.
    Lima JV; Scalissi NM; de Oliveira KC; Lindsey SC; Olivati C; Ferreira EN; Kater CE
    Endocr Oncol; 2023 Jan; 3(1):e220091. PubMed ID: 37529773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDHA-related phaeochromocytoma and paraganglioma: review and clinical management.
    Kaplan AI; Dwight T; Luxford C; Benn DE; Clifton-Bligh RJ
    Endocr Relat Cancer; 2024 Oct; 31(10):. PubMed ID: 39133175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
    Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
    Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
    Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma.
    Ma X; Ling C; Zhao M; Wang F; Cui Y; Wen J; Ji Z; Zhang C; Chen S; Tong A; Li Y
    Front Endocrinol (Lausanne); 2022; 13():921645. PubMed ID: 35966080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
    Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.
    Burnichon N; Buffet A; Gimenez-Roqueplo AP
    Curr Opin Oncol; 2016 Jan; 28(1):5-10. PubMed ID: 26599293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma.
    Kim JH; Kim MJ; Kong SH; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    J Med Genet; 2022 Jan; 59(1):56-64. PubMed ID: 33219105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mutation in the TMEM127 gene associated with phaeochromocytoma.
    Elston MS; Meyer-Rochow GY; Prosser D; Love DR; Conaglen JV
    Intern Med J; 2013 Apr; 43(4):449-51. PubMed ID: 23551308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.